OceanTech Acquisitions I said $30,000 was deposited into the company’s trust to extend its completion deadline until April 2.

Shareholders approved the deal last month, with REgentis Biomaterials although final redemptions reached 99.9% and there is a $6 million minimum cash condition to close the deal, according to the amended proxy filed in January. Following the merger vote, the SPAC had about $143,000 remaining in trust.

OceanTech’s sponsor has agreed to use reasonable best efforts to raise additional funding via a pijp.

Israel-based Regentis is a regenerative medicine company developing tissue repair solutions. Lees meer.

Bron: OceanTech Acquisitions I Extends Deadline by Another Month as it Works to Close Shareholder-Approved Regentis Deal

• Door SEO aangedreven content en PR-distributie. Word vandaag nog versterkt.
• PlatoData.Network Verticale generatieve AI. Versterk jezelf. Toegang hier.
• PlatoAiStream. Web3-intelligentie. Kennis versterkt. Toegang hier.
• PlatoESG. carbon, CleanTech, Energie, Milieu, Zonne, Afvalbeheer. Toegang hier.
• Plato Gezondheid. Intelligentie op het gebied van biotech en klinische proeven. Toegang hier.
• Bron: https://spacfeed.com/oceantech-acquisitions-i-extends-deadline-by-another-month-as-it-works-to-close-shareholder-approved-regentis-deal